Clinical Trial Update: Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on mesenchymal stem cell transplantation in newly diagnosed type 1 diabetes patients, spanning Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mesenchymal stem cells transplantation (mesenchymal stem cells)

Snippet

Sponsor: Royan Institute | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: UNKNOWN